297 related articles for article (PubMed ID: 7950861)
1. Virus-specific cytotoxic T lymphocyte responses in patients infected with the human immunodeficiency virus, HIV-1.
Rivière Y
Cell Mol Biol (Noisy-le-grand); 1994; 40 Suppl 1():45-8. PubMed ID: 7950861
[TBL] [Abstract][Full Text] [Related]
2. Impact of antigen expression kinetics on the effectiveness of HIV-specific cytotoxic T lymphocytes.
van Baalen CA; Guillon C; van Baalen M; Verschuren EJ; Boers PH; Osterhaus AD; Gruters RA
Eur J Immunol; 2002 Sep; 32(9):2644-52. PubMed ID: 12207349
[TBL] [Abstract][Full Text] [Related]
3. Dual function of a human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte clone: inhibition of HIV replication by noncytolytic mechanisms and lysis of HIV-infected CD4+ cells.
Buseyne F; Février M; Garcia S; Gougeon ML; Rivière Y
Virology; 1996 Nov; 225(1):248-53. PubMed ID: 8918556
[TBL] [Abstract][Full Text] [Related]
4. The antiviral activity of HIV-specific CD8+ CTL clones is limited by elimination due to encounter with HIV-infected targets.
McKinney DM; Lewinsohn DA; Riddell SR; Greenberg PD; Mosier DE
J Immunol; 1999 Jul; 163(2):861-7. PubMed ID: 10395680
[TBL] [Abstract][Full Text] [Related]
5. Differential immunogenicity of HIV-1 clade C proteins in eliciting CD8+ and CD4+ cell responses.
Ramduth D; Chetty P; Mngquandaniso NC; Nene N; Harlow JD; Honeyborne I; Ntumba N; Gappoo S; Henry C; Jeena P; Addo MM; Altfeld M; Brander C; Day C; Coovadia H; Kiepiela P; Goulder P; Walker B
J Infect Dis; 2005 Nov; 192(9):1588-96. PubMed ID: 16206073
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of HIV-1-specific CD8 T-cell responses and their role in loss of viremia in children chronically infected with HIV-1 undergoing highly active antiretroviral therapy.
Zhang Z; Zhao QX; Fu JL; Yao JX; He Y; Jin L; Wang FS
Chin Med J (Engl); 2006 Dec; 119(23):1949-57. PubMed ID: 17199938
[TBL] [Abstract][Full Text] [Related]
7. Frequency of class I HLA-restricted anti-HIV CD8+ T cells in individuals receiving highly active antiretroviral therapy (HAART).
Gray CM; Lawrence J; Schapiro JM; Altman JD; Winters MA; Crompton M; Loi M; Kundu SK; Davis MM; Merigan TC
J Immunol; 1999 Feb; 162(3):1780-8. PubMed ID: 9973442
[TBL] [Abstract][Full Text] [Related]
8. Use of retroviral vectors for the analysis of SIV/HIV-specific CD8 T cell responses.
Negri DR; Buffa V; Leone P; Bona R; Borghi M; Carlini F; De Angelis F; Indraccolo S; Ensoli B; Cara A
J Immunol Methods; 2004 Aug; 291(1-2):153-63. PubMed ID: 15345313
[TBL] [Abstract][Full Text] [Related]
9. Recognition of two overlapping CTL epitopes in HIV-1 p17 by CTL from a long-term nonprogressing HIV-1-infected individual.
Harrer T; Harrer E; Barbosa P; Kaufmann F; Wagner R; Brüggemann S; Kalden JR; Feinberg M; Johnson RP; Buchbinder S; Walker BD
J Immunol; 1998 Nov; 161(9):4875-81. PubMed ID: 9794421
[TBL] [Abstract][Full Text] [Related]
10. Cytolytic T lymphocytes (CTLs) from HIV-1 subtype C-infected Indian patients recognize CTL epitopes from a conserved immunodominant region of HIV-1 Gag and Nef.
Thakar MR; Bhonge LS; Lakhashe SK; Shankarkumar U; Sane SS; Kulkarni SS; Mahajan BA; Paranjape RS
J Infect Dis; 2005 Sep; 192(5):749-59. PubMed ID: 16088824
[TBL] [Abstract][Full Text] [Related]
11. Identification of HLA-A*3101-restricted cytotoxic T-lymphocyte response to human immunodeficiency virus type 1 (HIV-1) in patients with chronic HIV-1 infection.
Borghan MA; Oka S; Takiguchi M
Tissue Antigens; 2005 Oct; 66(4):305-13. PubMed ID: 16185326
[TBL] [Abstract][Full Text] [Related]
12. Detection of a vigorous HIV-1-specific cytotoxic T lymphocyte response in cerebrospinal fluid from infected persons with AIDS dementia complex.
Jassoy C; Johnson RP; Navia BA; Worth J; Walker BD
J Immunol; 1992 Nov; 149(9):3113-9. PubMed ID: 1383338
[TBL] [Abstract][Full Text] [Related]
13. CD8 lymphocytes in HIV infection: helpful and harmful.
Famularo G; Moretti S; Marcellini S; Nucera E; De Simone C
J Clin Lab Immunol; 1997; 49(1):15-32. PubMed ID: 9819670
[TBL] [Abstract][Full Text] [Related]
14. Induction of a MHC class I-restricted, CD8 positive cytolytic T-cell response by chimeric HIV-1 virus-like particles in vivo: implications on HIV vaccine development.
Wagner R; Deml L; Schirmbeck R; Reimann J; Wolf H
Behring Inst Mitt; 1994 Dec; (95):23-34. PubMed ID: 7755506
[TBL] [Abstract][Full Text] [Related]
15. Dysregulation of interleukin-7 receptor may generate loss of cytotoxic T cell response in human immunodeficiency virus type 1 infection.
Carini C; McLane MF; Mayer KH; Essex M
Eur J Immunol; 1994 Dec; 24(12):2927-34. PubMed ID: 7805718
[TBL] [Abstract][Full Text] [Related]
16. Accumulation of human immunodeficiency virus-specific cytotoxic T lymphocytes away from the predominant site of virus replication during primary infection.
Pantaleo G; Soudeyns H; Demarest JF; Vaccarezza M; Graziosi C; Paolucci S; Daucher MB; Cohen OJ; Denis F; Biddison WE; Sekaly RP; Fauci AS
Eur J Immunol; 1997 Dec; 27(12):3166-73. PubMed ID: 9464802
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxic T lymphocyte responses in the peripheral blood of children born to human immunodeficiency virus-1-infected mothers.
Cheynier R; Langlade-Demoyen P; Marescot MR; Blanche S; Blondin G; Wain-Hobson S; Griscelli C; Vilmer E; Plata F
Eur J Immunol; 1992 Sep; 22(9):2211-7. PubMed ID: 1381309
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxic T lymphocyte activity in children infected with HIV.
Froebel KS; Aldhous MC; Mok JY; Hayley J; Arnott M; Peutherer JF
AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S83-8. PubMed ID: 7865339
[TBL] [Abstract][Full Text] [Related]
19. CD8(+)-Cell antiviral factor activity is not restricted to human immunodeficiency virus (HIV)-specific T cells and can block HIV replication after initiation of reverse transcription.
Le Borgne S; Février M; Callebaut C; Lee SP; Rivière Y
J Virol; 2000 May; 74(10):4456-64. PubMed ID: 10775581
[TBL] [Abstract][Full Text] [Related]
20. Presence of HLA-C-restricted cytotoxic T-lymphocyte responses in long-term nonprogressors infected with human immunodeficiency virus.
Nehete PN; Lewis DE; Tang DN; Pollack MS; Sastry KJ
Viral Immunol; 1998; 11(3):119-29. PubMed ID: 9918403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
